Patients who experienced a hospitalization with infection had a higher risk of a subsequent dementia diagnosis years later compared to those who had not, according to a new study published in JAMA Network Open.

Without access to employer-sponsored insurance or federal subsidies for a marketplace plan, Jeff King, a 63-year-old evangelical pastor, turned to a non-insurance "medical cost-sharing" plan. However, the plan's coverage had limitations on pre-existing conditions, which ultimately left King with a $160,000 medical bill after a necessary procedure, Bram Sable-Smith writes in NPR's "Shots."

Day One Biopharmaceuticals on Sunday announced that its targeted therapy, tovorafenib, shrank tumors by at least 50% in most children diagnosed with the most common type of pediatric brain cancer, setting the stage for the approval of a new treatment for a rare, chronic disease, Jason Mast writes for STAT+.

Writing for the Harvard Business Review, executive coach Rebecca Zucker explains how leaders can set their teams up for success in the new year by reflecting on past successes and failures while looking for ways to improve and innovate.

AstraZeneca on Monday announced plans to purchase CinCor Pharma for up to $1.8 billion, in today's bite-sized hospital and health industry news from Delaware, Maryland, and Washington.